Fas ligand (FasL/CD95L), triggering apoptotic cell death following ligation to Fas (CD95/APO-1), helps to maintain tumor cells in a state of immune privilege by inducing apoptosis of anti-tumor immune effector cells [194]. This evidence concerns the gene FASLG and neoplasm.